Effect of Hydroxytyrosol Derivatives of Donepezil on the Activity of Enzymes Involved in Neurodegenerative Diseases and Oxidative Damage

Effect of Hydroxytyrosol Derivatives of Donepezil on the Activity of Enzymes Involved in Neurodegenerative Diseases and Oxidative Damage

Monoamine oxidase and xanthine oxidase inhibitors represent useful multi-target drugs for the prevention, attenuation, and treatment of oxidative damage and neurodegenerative disorders. Chimeric molecules, constituted by naturally derived compounds linked to drugs, represent lead compounds to be exp...

Full description

Bibliographic Details
Main Authors:	Antonio D’Errico, Rosarita Nasso, Rosario Rullo, Jessica Maiuolo, Paola Costanzo, Sonia Bonacci, Manuela Oliverio, Emmanuele De Vendittis, Mariorosario Masullo, Rosaria Arcone
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Molecules
Subjects:	hydroxytyrosol-donepezil hybrid inflammatory diseases neurodegenerative disorders monoamine oxidase (MAO) xanthine oxidase (XO) multitargeting agents
Online Access:	https://www.mdpi.com/1420-3049/29/2/548

Similar Items

Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme
by: Rosario Rullo, et al.
Published: (2023-03-01)

Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ in vivo
by: Gabriela A. Perez-Barron, et al.
Published: (2020-01-01)

Inhibition of Enzymes Involved in Neurodegenerative Disorders and A<i>β</i><sub>1–40</sub> Aggregation by <i>Citrus limon</i> Peel Polyphenol Extract
by: Rosaria Arcone, et al.
Published: (2023-08-01)

<i>Annurca</i> Apple Polyphenol Extract Affects Acetyl- Cholinesterase and Mono-Amine Oxidase In Vitro Enzyme Activity
by: Rosarita Nasso, et al.
Published: (2021-01-01)

First Synthesis of Racemic <i>Trans</i> Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
by: Benjamin Guieu, et al.
Published: (2020-12-01)

Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase
by: Mai Sekine, et al.
Published: (2021-11-01)

The Role of Xanthine Oxidase in Pregnancy Complications: A Systematic Review
by: Lorenzo Annesi, et al.
Published: (2024-10-01)

Novel Hydroxytyrosol-Donepezil Hybrids as Potential Antioxidant and Neuroprotective Agents
by: Paola Costanzo, et al.
Published: (2021-10-01)

Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity
by: Bonka Lozanska, et al.
Published: (2022-12-01)

Regulation of aging by balancing mitochondrial function and antioxidant levels
by: Sawako Yoshina, et al.
Published: (2022-11-01)

Quantitative Structure–Neurotoxicity Assessment and In Vitro Evaluation of Neuroprotective and MAO-B Inhibitory Activities of Series <i>N</i>′-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides
by: Magdalena Kondeva-Burdina, et al.
Published: (2022-08-01)

Design, synthesis and evaluation of semi- and thiosemicarbazides containing a methylxanthine moiety with in vitro neuroprotective and MAO-B inhibitory activities
by: Javor Mitkov, et al.
Published: (2022-12-01)

An investigation of the monoamine oxidase inhibition properties of benzothiazole derivatives
by: Anandie le Roux, et al.
Published: (2025-03-01)

Synthesis of 1,2,4-Oxadiazin-5(6<i>H</i>)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors
by: Sofia I. Presnukhina, et al.
Published: (2024-11-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

A review on coumarin backbone: An attractive scaffold for promising bioactive compounds
by: Sara Jasim, et al.
Published: (2022-01-01)

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01)

Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B
by: Jeffrey H. Meyer, et al.
Published: (2022-02-01)

Molybdenum’s Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review
by: Jakub Piotr Adamus, et al.
Published: (2024-07-01)

Reactive oxygen species in cardiovascular diseases: an update
by: Juanjuan Fei, et al.
Published: (2022-04-01)

Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01)

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education
by: Richard G. Wenzel, et al.
Published: (2010-06-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration
by: Emanuela Berrino, et al.
Published: (2023-11-01)

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
by: Ilana Berlowitz, et al.
Published: (2022-05-01)

Harmane Potentiates Nicotine Reinforcement Through MAO-A Inhibition at the Dose Related to Cigarette Smoking
by: Zheng Ding, et al.
Published: (2022-06-01)

The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
by: Monique Hoon, et al.
Published: (2017-11-01)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
by: Irene Pachón-Angona, et al.
Published: (2019-01-01)

Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
by: Edward E. Putnins, et al.
Published: (2021-11-01)

Phân lập và khảo sát điều kiện tối ưu cho hoạt động của enzyme xanthine oxidase từ sữa bò
by: Từ Văn Quyền, et al.
Published: (2018-04-01)

Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome
by: Masanari Kuwabara, et al.
Published: (2024-01-01)

Catalysis & inhibition issues associated with Monoamine Oxidase (MAO). How unusually low α-C-H bond dissociation energies may open the door to single electron transfer
by: Jonathan Sánchez González, et al.
Published: (2023-12-01)

Synthesis of Copper Ion Incorporated Xanthine Oxidase-Based Hybrid Nanoflowers
by: Burcu Somtürk Yilmaz, et al.
Published: (2020-02-01)

Comparative effects of green and black tea extracts on lowering serum uric acid in hyperuricemic mice
by: Chuang Zhu, et al.
Published: (2017-01-01)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
by: Ajmal Khan, et al.
Published: (2022-12-01)

Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B
by: Ahmed Elkamhawy, et al.
Published: (2020-01-01)

Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
by: Iyman Alsaad, et al.
Published: (2024-12-01)

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
by: Leonardo Pisani, et al.
Published: (2022-10-01)

Long-Term Effect of Febuxostat on Endothelial Function in Patients With Asymptomatic Hyperuricemia: A Sub-Analysis of the PRIZE Study
by: Tatsuya Maruhashi, et al.
Published: (2022-04-01)